New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Omega Healthcare Investors, Inc.

OHI

Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.

Revenue
+9.30%
EPS
−54.2%
Free cash flow
n/m
Total debt
−19.5%

Quarter to September 2026, against a year earlier

45.53 0.39 −0.85%

After hours trading: 45.09, down 0.97%, last trade 7:27pm Eastern.

Market cap
$14.0B
P/E
18.2×
Fwd P/E FY26e
19.4×
Dividend yield
5.93%
F-score
6/9
ROIC
4.65%
Net debt / EBITDA
4.0×
Payout ratio
1.1×

Ratios over time FY16 to FY25

Returns on capital

ROIC was 4.65% in FY25, the highest of these ten years. ROE, at 11.6%, is far above it because equity is small against the capital the business uses.

ROEROIC
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
ROE8.8%2.5%7.4%8.4%3.8%10.2%11.1%6.6%9.8%11.6%
ROIC4.1%2.4%3.6%3.3%2.6%3.5%2.2%2.9%4.3%4.6%

Debt

Net debt is 4.03× a year’s EBITDA. Debt is 0.78× equity, against 1.39× in FY22.

Debt / equityNet debt / EBITDA
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Debt / equity1.0×1.2×1.2×1.2×1.3×1.3×1.4×1.3×1.0×0.8×
Net debt / EBITDA5.2×7.3×6.0×6.4×7.1×5.8×7.6×6.4×4.6×4.0×

Per share, from FY16

Since FY16, per share: revenue has fallen 1.55% a year; book value has fallen 1.80% a year.

RevenueBook value
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue1.0×1.0×0.9×0.9×0.8×1.0×0.8×0.8×0.9×0.9×
Book value1.0×0.9×0.9×0.9×0.8×0.8×0.7×0.7×0.8×0.8×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
6 7 6 6 6 5 4 4 4 6
P/E ratio
22.74 24.11 31.16 15.53 16.72 51.15 26.47 25.11 54.86 16.82
P/S ratio
10.87 9.29 7.81 7.52 6.60 9.27 9.73 7.98 5.97 6.80
P/FCF ratio
159.52 41.74 27.20 19.93 0.00 16.66 0.00 31.29 51.26 0.00
P/Operating CF
56.07 42.67 44.97 42.98 44.79 41.91 61.07 46.65 36.01 36.57
P/B ratio
2.38 2.07 1.97 1.74 1.71 2.05 2.08 1.87 1.40 1.45
EV/Sales
11.02 13.37 12.68 13.20 11.52 14.87 15.22 13.12 10.90 11.53
EV/EBITDA
12.57 14.94 16.60 17.78 13.66 18.74 17.64 15.38 16.21 12.60
EV/FCF
161.84 60.07 44.15 34.98 (362.68) 26.74 (848.56) 51.42 93.56 (23.37)
Current Ratio
5.04 7.07 6.76 5.01 4.84 3.79 2.67 2.78 3.55 2.74
Net Debt/EBITDA
4.03 4.56 6.37 7.65 5.84 7.06 6.37 6.02 7.33 5.17
Debt/Equity
0.78 1.02 1.35 1.39 1.28 1.28 1.18 1.21 1.18 1.04
ROE
11.63% 9.85% 6.59% 11.09% 10.23% 3.81% 8.42% 7.36% 2.48% 8.82%
ROA
5.93% 4.40% 2.69% 4.61% 4.36% 1.65% 3.71% 3.24% 1.13% 4.33%
ROIC
4.65% 4.32% 2.92% 2.22% 3.48% 2.63% 3.28% 3.56% 2.36% 4.13%
Return on Tangible Assets
7.28% 5.02% 3.30% 5.63% 5.27% 2.13% 4.42% 4.22% 1.43% 5.27%
Average Days of Receivables
104.29 119.73 110.49 97.05 46.52 4.26 10.66 14.00 112.24 97.26
Earnings Yield
4.40% 4.15% 3.21% 6.44% 5.98% 1.95% 3.78% 3.98% 1.82% 5.95%
Free Cash Flow Yield
0.63% 2.40% 3.68% 5.02% (0.48%) 6.00% (0.18%) 3.20% 1.95% (7.25%)
Free Cash Flow per Share
0.28 0.91 1.13 1.40 (0.14) 2.18 (0.08) 1.12 0.54 (2.32)
Book value per Share
18.65 18.33 15.64 16.10 17.34 17.72 20.32 18.80 19.66 21.96
Free Cash Flow
81.06 234.07 272.78 331.39 (33.75) 496.41 (16.66) 224.99 105.81 (444.43)
EV/EBIT
18.29 22.52 30.74 37.18 23.52 34.85 28.51 24.47 31.41 18.55
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 18, 2026